Lymphoedema Evidence Library › Topics › Decongestive therapy, MLD and exercise
Decongestive therapy, MLD and exercise
Decongestive therapy (CDT), MLD, exercise and taping
82 sources
Evidence in one minute
- CDT = intensive phase (skin care, MLD, exercise, multilayer short-stretch bandaging; daily for 2–4 weeks) then maintenance (garments, self-care, exercise, self-MLD). It is the accepted standard in every guideline held, on long experience rather than trials. Executive Committee of the International Society of Lymphology 2023 · Lymphoedema Framework 2006 · Davey 2018
- MLD: acutely increases lymphatic pumping (ICG: velocity +23–28%) and local tissue water falls after one session — but meta-analyses show little added volume reduction over compression and exercise (BCRL). Use for pain, tightness, areas hard to compress (head/neck, breast, trunk). Tan 2011 · Mayrovitz 2008 · Executive Committee of the International Society of Lymphology 2023
- Therapist opinion is moving the same way: less MLD, more compression, exercise and weight loss. Nikolaidis 2013 · Marco 2014
- Exercise is safe and beneficial; aim ≥150 min/week moderate mixed exercise; lower-limb exercise framework from a 2025 Delphi. Davies 2026
- Taping: no volume benefit (low certainty); function and comfort gains very low certainty — the review's abstract omits the null main outcome (revised 2026-10-08). Yang 2024
- Diuretics: of marginal benefit and potentially harmful long term; benzopyrones/coumarin not a substitute for CDT; no diet proven. Executive Committee of the International Society of Lymphology 2023 · National Lymphedema Network Medical Advisory Committee 2011
- After surgery, conservative therapy continues for life. Flores 2024
- Low-level laser: immediate softening and water reduction of fibrotic skin greater than sham — mechanistic only. Mayrovitz 2011
Certainty: compression component — moderate to high in BCRL; MLD as add-on — moderate certainty of no clinically important effect (revised 2026-10-09, EFforT-BCRL); CDT package — accepted practice, low-quality comparative evidence.
Practical SA points
Certified therapists require ≥135 hours training (LAOSA register); medical aids often fund poorly; a simplified, compression-led programme is realistic where therapist time is scarce.
Update 2026-10-08 — downloaded evidence
- MLD (Cochrane): adds ~7% of excess volume to bandaging (2 RCTs, 83 patients; the ml outcomes not significant) — low certainty; the "mild BCRL" subgroup came from a data-driven cut-point search (very low) (revised 2026-10-08); review of reviews 2024: no additional volume benefit; exercise helps pain/QoL. Ezzo 2015 · Gilchrist 2024
- No conservative treatment proven superior to another; harms rare. Oremus 2012
- Benzopyrones (coumarin, oxerutin, diosmin): no reliable benefit, hepatotoxicity (Cochrane). Badger 2004
- Self-care training works (filarial attacks −54%; home exercise with deep breathing reduces cancer-related volume). Douglass 2016
- Exercise guidance for cancer survivors (ACSM 2019). Campbell 2019
Update 2026-10-09 — open-access batch 1 (2020–2026 trials and reviews)
- Exercise and prevention (revised 2026-10-09): pooled RR 0.71 for developing cancer-related lymphoedema (low certainty), not significant for breast cancer alone. Plinsinga 2026
- Wraps in the intensive phase: non-inferior to bandaging over 10 days (low certainty, manufacturer-funded). Reisshauer 2025
Update 2026-10-09 — open-access batch 2
- MLD (revised 2026-10-09): the three-arm EFforT-BCRL RCT (194 women, sham-controlled, blinded) found neither ICG-guided nor traditional MLD added anything to bandaging, garments, exercise and skin care (difference 0.0 percentage points, −2.0 to 2.1) — moderate certainty of no clinically important benefit in chronic BCRL. De Vrieze T 2022
- Early BCRL — intensive DLT v garment self-treatment: no trial shows intensive two-phase therapy beats garments alone for swelling under 12 months (the one adequate RCT, Dayes 2013, was null) — very low. Jeffs 2024
- Night compression after intensive therapy: adding a night sleeve kept excess volume down over 3 months (−16% v +12%) — low, manufacturer-funded. Borman 2026
Update 2026-10-09 — open-access batch 4
- Self-administered CDT (Gultekin 2025, 50 women, Turkey): after teaching by a certified therapist, self-CDT gave the same volume reduction as therapist CDT (−568 v −567 mL) to 3 months — low; no non-inferiority margin and retrospective registration. Relevant to SA staffing. Gultekin 2025
- Taping instead of bandaging gives a smaller reduction — low. Pajero Otero V 2022
Update 2026-10-09 — open-access batch 5
- Bandage pressure: 45–55 mmHg was not better than 20–30 mmHg for volume in a 21-patient trial (between-group p 0.13–0.55), despite its abstract — very low. Lower pressures remain reasonable. Duygu-Yildiz 2023
- Add-ons that did not reduce volume: myofascial release (Kim 2023, 3 mL difference; may help shoulder pain) and VR v PNF exercise (Atef 2020, Egypt) — low/very low. Kim 2023 · Atef 2020
- Exercise in bandages: supine cycling gave about 1% more immediate leg volume reduction than bandages alone (Abe 2021) — low. Abe 2021
Update 2026-10-09 — open-access batch 8 (reviews)
- MLD meta-analysis (Liang 2020): no pooled benefit for treatment (SMD −0.09) or prevention (RR 0.61, 0.29–1.26) — low; its two "positive" subgroups are the same data. Liang 2020
Update 2026-10-09 — open-access batch 11 (reviews)
- Shamoun 2023 CDT meta-analysis: all pooled effects null and estimates outside their own CIs, yet concludes CDT works — disregard. Shamoun 2023
- Therapy around microsurgery: no evidence-based protocol (Doubblestein 2023). Doubblestein 2023
How the evidence points
| High | Mod. | Low | V. low | None | |
|---|---|---|---|---|---|
| Positive | 0 | 0 | 10 | 8 | 0 |
| Null or negative | 0 | 1 | 8 | 3 | 0 |
Sources on this page with a comparison, by the result of their primary outcome and the GRADE certainty of their main finding (Mod. = Moderate, V. low = Very low, None = not graded). Context sources are not counted. How direction is decided.
All 82 sources
Loading 82 sources…